Cambridge Quantum Computing (CQC) has just announced their collaboration with Roche, to design and implement noisy-intermediate-scale-quantum (NISQ) algorithms for early-stage drug discovery and development.
The multi-year collaboration will combine the expertise of both CQC and Roche to significantly advance the application of Quantum Computing to pharmaceutical relevant problems– accelerating the industry closer towards quantum advantage.
The collaboration will employ CQC’s quantum chemistry platform ‘EUMEN’, to augment the Alzheimer’s Disease research efforts of Roche.
Read more.
The post CQC and Roche partnership in drug discovery appeared first on Swiss Quantum Hub.